CD44 SNP rs187115: A novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma.

<h4>Purpose</h4> <p>Although pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor, like other common cancers, it displays a wide range of biology. However, at present, there are no reliable tests to predict patients’ cancer-specific outcomes and guide personalized treatme...

Full description

Bibliographic Details
Main Authors: Stracquadanio, G, Vrugt, B, Flury, R, Schraml, P, Würl, P, Müller, T, Knippschild, U, Henne-Bruns, D, Breitenstein, S, Clavien, P, Graf, R, Bond, G, Grochola, L
Format: Journal article
Language:English
Published: American Association for Cancer Research 2016

Similar Items